Furthermore, lung cancer patients with both elevated lnc-MLETA1 and EGFR or IGF1R displayed the worst survival, indicating the superior prognostic value of combining the two parameters compared with one gene alone (Fig. 7I and J). This evidence concerns the gene EGFR and lung carcinoma.